A roundup of 2025's most impactful nanomaterial innovations. From energy storage and flexible electronics to cancer treatment ...

Biocon's share price rose 5.5% after USFDA approved JOBEVNE, a biosimilar cancer drug. This marks the company's seventh USFDA ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

Biocon Biologics, a subsidiary of Biocon Ltd, announced on Thursday that it has received approval from the United States Food ...

Amezalpat (TPST-1120) is Phase 3-ready: completed FDA and EMA interactions for first-line pivotal study in hepatocellular carcinoma (HCC); global ...

Bone regeneration continues to be a critical challenge in tissue engineering, with unpredictable outcomes often hindering ...

Increased dietary folic acid intake may lead to adverse health effects, including inflammation and neurotoxicity, ...

Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...

Download this technical note to explore how a qualitative, real-time, high-throughput in vitro tube formation assay helps ...

A research team led by the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences has constructed ...

Tharimmune (THAR) announced preclinical data from its expanded pipeline with HS1940, a dual-target multispecific biologic engineered to bind to ...

The ranibizumab biosimilar Ongavia exhibited significantly less improvement in visual acuity and retinal thickness compared ...